CURRENT REPORT

Company

Actinium Pharmaceuticals, Inc.

Filed

July 28, 2017

Period of Report

July 27, 2017

Accession Number

0001213900-17-007992

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →